Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

137 evidence items · page 6 / 6

57 %57% of individuals in the MIM profile had knowledge of the symptoms of COVID-19.

MaliCOVID-19HAL · Unilimdocument of 88 observations

29 %29% of individuals in the INO profile strongly agreed that COVID-19 was introduced by white people.

MaliCOVID-19HAL · Unilimdocument of 88 observations

9 deathsThe officially reported number of COVID-19 deaths in the Tombouctou population was 9.

MaliCOVID-19HAL · Unilimdocument of 88 observations

14.1 %The non-specific binding of antibody samples in COVID-19 patients accounted for 14.1% (12 out of 85) of the seroreactive samples for RBD and RBM.

MaliCOVID-19HAL · Unilimdocument of 67 observations

0.609 ODIn the COVID-19 patient group, the median optical density (OD) for anti-S antibody was 0.609 (Q1; Q3: 0.333; 1.260) in males and 0.712 (Q1; Q3: 0.339; 1.193) in females.

MaliCOVID-19HAL · Unilimdocument of 67 observations

0.174 ODIn the COVID-19 patient group, the median optical density (OD) for anti-RBM antibody was 0.174 (Q1; Q3: 0.130; 0.251) in males and 0.186 (Q1; Q3: 0.123; 0.300) in females.

MaliCOVID-19HAL · Unilimdocument of 67 observations

72 %Parmi les 1 164 patients inclus, 835 (72 %) remplissaient les critères de suspicion de COVID-19.

MaliCOVID-19observed June 2022 and September 2022HAL · Unilimdocument of 36 observations

Seroprevalence of SARS-CoV-2 was higher among older age groups in Tombouctou.

MaliCOVID-19HAL · Unilimdocument of 88 observations

0.76 %In Tombouctou health district, 532 confirmed cases of COVID-19 represented 0.76% of the general population.

MaliCOVID-19HAL · Unilimdocument of 88 observations

80.5 %Among COVID-19 patients (n = 266), 80.5% responded to the S antigen.

MaliCOVID-19HAL · Unilimdocument of 67 observations

33.5 %The seroprevalence of SARS-CoV-2 in the urban commune of Tombouctou was 33.5% (95% CI: 30.4% to 36.6%).

MaliCOVID-19observed January 2021HAL · Unilimdocument of 88 observations

33.5 %The crude seroprevalence of SARS-CoV-2 in Tombouctou was 33.5% (95% CI: 30.4% to 36.6%) among 923 tested individuals aged at least 1 year.

MaliCOVID-19observed January 2021HAL · Unilimdocument of 88 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.